Corcept Therapeutics Inc (CORT)
22.81
+0.60
(+2.70%)
USD |
NASDAQ |
Apr 26, 16:00
22.81
0.00 (0.00%)
After-Hours: 20:00
Corcept Therapeutics Free Cash Flow: 126.90M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | 126.90M |
| September 30, 2023 | 154.37M |
| June 30, 2023 | 134.80M |
| March 31, 2023 | 110.63M |
| December 31, 2022 | 119.91M |
| September 30, 2022 | 135.92M |
| June 30, 2022 | 151.16M |
| March 31, 2022 | 177.36M |
| December 31, 2021 | 167.42M |
| September 30, 2021 | 152.70M |
| June 30, 2021 | 133.88M |
| March 31, 2021 | 142.80M |
| December 31, 2020 | 150.73M |
| September 30, 2020 | 164.41M |
| June 30, 2020 | 172.83M |
| March 31, 2020 | 144.83M |
| December 31, 2019 | 135.03M |
| September 30, 2019 | 108.12M |
| June 30, 2019 | 114.44M |
| March 31, 2019 | 104.44M |
| December 31, 2018 | 115.37M |
| September 30, 2018 | 118.82M |
| June 30, 2018 | 85.20M |
| March 31, 2018 | 85.42M |
| December 31, 2017 | 60.52M |
| Date | Value |
|---|---|
| September 30, 2017 | 40.16M |
| June 30, 2017 | 38.16M |
| March 31, 2017 | 24.37M |
| December 31, 2016 | 18.20M |
| September 30, 2016 | 17.88M |
| June 30, 2016 | 9.921M |
| March 31, 2016 | 8.199M |
| December 31, 2015 | 3.113M |
| September 30, 2015 | -2.47M |
| June 30, 2015 | -9.298M |
| March 31, 2015 | -18.19M |
| December 31, 2014 | -27.55M |
| September 30, 2014 | -33.85M |
| June 30, 2014 | -36.58M |
| March 31, 2014 | -36.78M |
| December 31, 2013 | -37.18M |
| September 30, 2013 | -38.28M |
| June 30, 2013 | -38.89M |
| March 31, 2013 | -37.58M |
| December 31, 2012 | -36.17M |
| September 30, 2012 | -33.66M |
| June 30, 2012 | -30.99M |
| March 31, 2012 | -30.27M |
| December 31, 2011 | -27.40M |
| September 30, 2011 | -26.56M |
Free Cash Flow Range, Past 5 Years
108.12M
Minimum
Sep 2019
177.36M
Maximum
Mar 2022
142.01M
Average
142.80M
Median
Mar 2021
Free Cash Flow Benchmarks
| Ultragenyx Pharmaceutical Inc | -521.57M |
| Alnylam Pharmaceuticals Inc | 41.94M |
| Catalyst Pharmaceuticals Inc | 61.86M |
| United Therapeutics Corp | 747.60M |
| XOMA Corp | -18.16M |